Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice

Kathryn P. MacPherson(Emory University), Malú G. Tansey(Czech Academy of Sciences, Institute of Physiology)
Neurobiology of Disease
February 24, 2017
Cited by 155


Related Papers